The first part of this animation explains the inflammatory storm caused by an overactive immune response is the critical cause of mortality in severe COVID-19 patients. The second part demonstrates that the Tocilizumab treatment developed from the University of Science and Technology of China (USTC) has contributed to the fight against COVID-19.